Avidity Partners Management LP
- SEC CIK
- 0001791827
- Latest filing
- Aug 14, 2026
Holdings in Q3 2024
Holdings as of Sep 30, 2024, filed Nov 14, 2024. Long positions only; changes compare share counts with Q2 2024.
- Positions
- 81
- −4 vs. Q2 2024
- Portfolio value
- $1.96B
- −$393.0M (−16.7%) vs. Q2 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BSXBoston Scientific Corp | Stock | 962,000 | $80.6M | 4.1% | −208,100−17.8% | Reduced | History |
| DNTHDianthus Therapeutics, Inc. | COM | 2,917,231 | $79.9M | 4.1% | 00.0% | Unchanged | History |
| ISRGIntuitive Surgical Inc | COM NEW | 148,200 | $72.8M | 3.7% | −96,800−39.5% | Reduced | History |
| NTRANatera, Inc. | COM | 556,400 | $70.6M | 3.6% | −210,100−27.4% | Reduced | History |
| CGONCG Oncology, Inc. | COM | 1,656,000 | $62.5M | 3.2% | +359,775+27.8% | Added | History |
| ACHCAcadia Healthcare Company, Inc. | COM | 985,000 | $62.5M | 3.2% | −135,000−12.1% | Reduced | History |
| NBIXNeurocrine Biosciences Inc | Stock | 460,000 | $53.0M | 2.7% | −31,000−6.3% | Reduced | History |
| UNHUnitedHealth Group Inc | Stock | 87,400 | $51.1M | 2.6% | +87,400 | New | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 431,000 | $48.0M | 2.4% | −113,500−20.8% | Reduced | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 2,455,000 | $47.3M | 2.4% | −880,000−26.4% | Reduced | History |
| CATXPerspective Therapeutics, Inc. | COM NEW | 3,444,002 | $46.0M | 2.3% | +406,334+13.4% | Added | History |
| GKOSGLAUKOS Corp | COM | 344,900 | $44.9M | 2.3% | +120,900+54.0% | Added | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 1,373,000 | $43.5M | 2.2% | +256,000+22.9% | Added | History |
| INSMINSMED Inc | COM PAR $.01 | 592,000 | $43.2M | 2.2% | +162,000+37.7% | Added | History |
| TMOThermo Fisher Scientific Inc. | Stock | 68,600 | $42.4M | 2.2% | −11,400−14.2% | Reduced | History |
| THCTenet Healthcare Corp | COM NEW | 253,000 | $42.0M | 2.1% | −119,000−32.0% | Reduced | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 752,000 | $41.8M | 2.1% | −208,000−21.7% | Reduced | History |
| HUMHumana Inc | Stock | 129,700 | $41.1M | 2.1% | +129,700 | New | History |
| EXASExact Sciences Corp | COM | 588,000 | $40.1M | 2.0% | +249,500+73.7% | Added | History |
| ILMNIllumina, Inc. | COM | 292,000 | $38.1M | 1.9% | −186,000−38.9% | Reduced | History |
| ARVNArvinas, Inc. | COM | 1,497,000 | $36.9M | 1.9% | −1,490,845−49.9% | Reduced | History |
| RVMDRevolution Medicines, Inc. | COM | 790,000 | $35.8M | 1.8% | +35,000+4.6% | Added | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 2,132,000 | $34.1M | 1.7% | +2,132,000 | New | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 1,804,493 | $32.6M | 1.7% | +184,493+11.4% | Added | History |
| XENEXenon Pharmaceuticals Inc. | COM | 818,000 | $32.2M | 1.6% | +64,000+8.5% | Added | History |
| AVTRAvantor, Inc. | COM | 1,235,000 | $31.9M | 1.6% | −1,851,000−60.0% | Reduced | History |
| BPMCBlueprint Medicines Corp | COM | 315,000 | $29.1M | 1.5% | −68,000−17.8% | Reduced | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 731,104 | $28.5M | 1.5% | 00.0% | Unchanged | History |
| SGRYSurgery Partners, Inc. | Stock | 827,000 | $26.7M | 1.4% | −479,477−36.7% | Reduced | History |
| AXSMAxsome Therapeutics, Inc. | COM | 296,100 | $26.6M | 1.4% | −79,900−21.3% | Reduced | History |
| DHRDanaher Corp | Stock | 95,000 | $26.4M | 1.3% | −55,000−36.7% | Reduced | History |
| JANXJanux Therapeutics, Inc. | COM | 562,000 | $25.5M | 1.3% | −278,219−33.1% | Reduced | History |
| NMRANeumora Therapeutics, Inc. | COM | 1,800,000 | $23.8M | 1.2% | 00.0% | Unchanged | History |
| KYMRKymera Therapeutics, Inc. | COM | 500,000 | $23.7M | 1.2% | +500,000 | New | History |
| BHVNBiohaven Ltd. | COM | 465,000 | $23.2M | 1.2% | +15,000+3.3% | Added | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 320,000 | $22.5M | 1.1% | +320,000 | New | History |
| ARGXArgenx SE | SPONSORED ADR | 38,200 | $20.7M | 1.1% | −22,300−36.9% | Reduced | History |
| INCYIncyte Corp | COM | 308,110 | $20.4M | 1.0% | −220,890−41.8% | Reduced | History |
| ABBVAbbVie Inc. | Stock | 100,000 | $19.7M | 1.0% | −177,800−64.0% | Reduced | History |
| ORKAOruka Therapeutics, Inc. | COM | 790,926 | $19.4M | 1.0% | +790,926 | New | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 430,900 | $18.9M | 1.0% | −644,100−59.9% | Reduced | History |
| NGNENeurogene Inc. | COM | 425,041 | $17.8M | 0.9% | −302,496−41.6% | Reduced | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 2,133,872 | $17.8M | 0.9% | +2,133,872 | New | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 119,000 | $17.8M | 0.9% | +119,000 | New | History |
| BNTXBioNTech SE | SPONSORED ADS | 145,000 | $17.2M | 0.9% | +145,000 | New | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 233,000 | $17.0M | 0.9% | −167,000−41.8% | Reduced | History |
| KROSKeros Therapeutics, Inc. | COM | 293,200 | $17.0M | 0.9% | −50,000−14.6% | Reduced | History |
| DXCMDexcom Inc | COM | 240,000 | $16.1M | 0.8% | −19,000−7.3% | Reduced | History |
| ORICOric Pharmaceuticals, Inc. | COM | 1,447,119 | $14.8M | 0.8% | +1,447,119 | New | History |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 889,700 | $14.8M | 0.8% | +330,400+59.1% | Added | History |
| CNTXContext Therapeutics Inc. | COM | 7,417,155 | $14.5M | 0.7% | −2,2000.0% | Reduced | History |
| ZTSZoetis Inc. | Stock | 71,000 | $13.9M | 0.7% | +71,000 | New | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 749,000 | $13.8M | 0.7% | −351,000−31.9% | Reduced | History |
| IMUXImmunic, Inc. | COM | 8,266,000 | $13.6M | 0.7% | −636,972−7.2% | Reduced | History |
| BMYBristol Myers Squibb Co | Stock | 263,000 | $13.6M | 0.7% | +263,000 | New | History |
| IMNMImmunome Inc. | COM | 873,891 | $12.8M | 0.7% | 00.0% | Unchanged | History |
| RGNXREGENXBIO Inc. | COM | 1,132,564 | $11.9M | 0.6% | −167,500−12.9% | Reduced | History |
| COGTCogent Biosciences, Inc. | COM | 1,001,000 | $10.8M | 0.6% | +2940.0% | Added | History |
| APGEApogee Therapeutics, Inc. | COM | 154,000 | $9.05M | 0.5% | −333,000−68.4% | Reduced | History |
| PRVAPrivia Health Group, Inc. | COM | 466,800 | $8.50M | 0.4% | −297,400−38.9% | Reduced | History |
| HELPHelus Pharma Inc. | COM NEW | 918,000 | $8.16M | 0.4% | +918,000 | New | History |
| ESTAEstablishment Labs Holdings Inc. | COM | 169,000 | $7.31M | 0.4% | −362,000−68.2% | Reduced | History |
| CGEMCullinan Therapeutics, Inc. | COM | 425,000 | $7.11M | 0.4% | −1,134,826−72.8% | Reduced | History |
| IMCRImmunocore Holdings plc | ADS | 200,000 | $6.23M | 0.3% | 00.0% | Unchanged | History |
| DYNDyne Therapeutics, Inc. | COM | 165,000 | $5.93M | 0.3% | +165,000 | New | History |
| SNYSanofi | SPONSORED ADR | 100,000 | $5.76M | 0.3% | −215,000−68.3% | Reduced | History |
| EDITEditas Medicine, Inc. | COM | 1,465,000 | $5.00M | 0.3% | +649,000+79.5% | Added | History |
| TMDXTransMedics Group, Inc. | COM | 27,600 | $4.33M | 0.2% | +27,600 | New | History |
| KZRKezar Life Sciences, Inc. | COM | 5,026,000 | $3.89M | 0.2% | 00.0% | Unchanged | History |
| QUREuniQure N.V. | SHS | 673,618 | $3.32M | 0.2% | +673,618 | New | History |
| IMVTImmunovant, Inc. | COM | 99,000 | $2.82M | 0.1% | −809,000−89.1% | Reduced | History |
| ANROAlto Neuroscience, Inc. | COM SHS | 240,000 | $2.75M | 0.1% | +240,000 | New | History |
| PRMEPrime Medicine, Inc. | COM | 694,000 | $2.69M | 0.1% | 00.0% | Unchanged | History |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | 1,063,000 | $2.29M | 0.1% | −610,538−36.5% | Reduced | History |
| SCYXScynexis Inc | COM NEW | 1,448,728 | $2.16M | 0.1% | 00.0% | Unchanged | History |
| TILInstil Bio, Inc. | COM NEW | 29,100 | $1.96M | 0.1% | +29,100 | New | History |
| PRLDPrelude Therapeutics Inc | COM | 890,000 | $1.84M | 0.1% | +890,000 | New | History |
| KPTIKaryopharm Therapeutics Inc. | COM | 2,018,500 | $1.68M | 0.1% | 00.0% | Unchanged | History |
| HYPRHyperfine, Inc. | COM CL A | 1,188,178 | $1.28M | 0.1% | 00.0% | Unchanged | History |
| BLUEbluebird bio, Inc. | COM | 1,631,143 | $847.4K | <0.1% | +1,631,143 | New | History |
| CMAXCareMax, Inc. | COMM STK | 21,200 | $36.0K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q2 2024 (24)
Positions held at the end of Q2 2024 that are gone from this filing.
| Security | Class | Shares in Q2 2024 | Value in Q2 2024 | % of portfolio in Q2 2024 | History |
|---|---|---|---|---|---|
| CICigna Group | Stock | 184,500 | $61.0M | 2.6% | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 222,000 | $53.9M | 2.3% | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 48,000 | $50.4M | 2.1% | History |
| MRKMerck & Co., Inc. | Stock | 325,000 | $40.2M | 1.7% | History |
| UTHRUnited Therapeutics Corp | COM | 110,000 | $35.0M | 1.5% | History |
| LNTHLantheus Holdings, Inc. | Stock | 290,000 | $23.3M | 1.0% | History |
| PCVXVaxcyte, Inc. | COM | 284,000 | $21.4M | 0.9% | History |
| JSPRJasper Therapeutics, Inc. | COM NEW | 782,000 | $17.8M | 0.8% | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 398,000 | $17.6M | 0.7% | History |
| GILDGilead Sciences, Inc. | Stock | 255,000 | $17.5M | 0.7% | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 205,000 | $16.0M | 0.7% | History |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | 215,600 | $9.76M | 0.4% | History |
| Cybin Ord23256X100 | COM | 34,884,000 | $9.45M | 0.4% | – |
| TYRATyra Biosciences, Inc. | COM | 373,000 | $5.96M | 0.3% | History |
| PATHUiPath, Inc. | Stock | 362,000 | $4.59M | 0.2% | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 195,000 | $4.58M | 0.2% | History |
| IMTXImmatics N.V. | SHS | 393,100 | $4.57M | 0.2% | History |
| IONSIonis Pharmaceuticals Inc | COM | 93,000 | $4.43M | 0.2% | History |
| ORKAOruka Therapeutics, Inc. | COM | 1,000,000 | $3.83M | 0.2% | History |
| NTLAIntellia Therapeutics, Inc. | COM | 170,000 | $3.80M | 0.2% | History |
| COLLCollegium Pharmaceutical, Inc | COM | 117,000 | $3.77M | 0.2% | History |
| ACIUAC Immune SA | SHS | 825,000 | $3.29M | 0.1% | History |
| WVEWave Life Sciences, Inc. | SHS | 350,000 | $1.75M | 0.1% | History |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 12,136 | $1.94K | <0.1% | – |